logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
14/11/2025
Jahwa Biotech Holdings Limited has submitted its listing application to the Hong Kong Stock Exchange.
Latest
2 m ago
Cidara Therapeutics' pre-market stock increase has expanded to 105%, with Merck & Co. set to acquire the company for $221.5 per share in cash. The transaction is expected to be completed in the first quarter of 2026.
2 m ago
New stock news | Yingpai Pharmaceuticals plans to list in Hong Kong. The China Securities Regulatory Commission requires additional clarification on matters such as past capital increases and pricing basis for equity transfers.
2 m ago
Ministry of Finance: Promote financial reform management and accelerate the construction of a high-level socialist market economy system.
2 m ago
New Stocks Update | Wan Yuan Technology Plans to List on the Hong Kong Stock Exchange. The China Securities Regulatory Commission Requires Supplementary Explanation of the Company's Historical Background and Other Matters.
2 m ago
New Stock News | Rongtai Pharmaceuticals Plans to List in Hong Kong. China Securities Regulatory Commission requires additional explanation on the reasonableness of the price at which new shareholders have entered in the past year.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.